GlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company
17y agoen
From the article
Creates a new focused HIV business with the sustainability to deliver significant improvements in treatment, access and shareholder value.
Continue reading on GSKYou might also wanna read
Pfizer-Mylan Merger: The Making of The Pharma Giant
marketsandmarkets.com·6y ago
STAT+: Compass says depression drug has long-lasting benefits
STAT·1d ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
ft.trib.al·1mo ago
FDA Approves First 100% Effective HIV Prevention Drug with Global Impact
The article discusses the milestone approval of the first HIV prevention drug, lenacapavir (brand name Yeztugo), which offers 100% protectio
newatlas.com·11mo ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
STAT·2d ago
A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes
clinicaltrials.gov·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.